Search

Your search keyword '"CD40 Ligand blood"' showing total 774 results

Search Constraints

Start Over You searched for: Descriptor "CD40 Ligand blood" Remove constraint Descriptor: "CD40 Ligand blood"
774 results on '"CD40 Ligand blood"'

Search Results

1. The Influence of CD40/CD40L, MMP2/MMP9 on Uterine Artery Blood Flow and Their Expression in Recurrent Miscarriage.

2. Impact of CD40 (rs1883832) and CD40L (rs1126535) gene variants on laryngeal cancer susceptibility and their association with serum biomarker levels of sCD40 and sCD40L.

3. Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial.

4. Highly sensitive CD40L protein discrimination via label-free fiber sensing technologies.

5. Investigating soluble CD40 ligand as a prognostic factor among acute coronary syndromes patients: A multi-center prospective case-control study.

6. Analysis of the expression of cytokines and chemokines, platelet-leukocyte aggregates, sCD40L and sCD62P in cutaneous melanoma.

7. Analysis of the Relationship Between the Changes of Serum SAA, LP-PLA2, sCD40L and Carotid Atherosclerosis Plaque in Patients with Acute Cerebral Infarction.

8. Platelet transfusion enhances pro-aggregatory status shortly after coronary artery bypass grafting (CABG while modulating platelet pro-inflammatory state 1-week post-surgery.

9. Development of an immunoassay for quantification of soluble human CD40L (CD154) in plasma and serum samples.

10. Platelets mediate inflammatory monocyte activation by SARS-CoV-2 spike protein.

11. Dysregulated CD40 and CD40 ligand expression in anti-N-methyl-d-aspartate receptor encephalitis.

12. Successful Milk Oral Immunotherapy Promotes Generation of Casein-Specific CD137 + FOXP3 + Regulatory T Cells Detectable in Peripheral Blood.

13. Evaluation of Potential Antigen-specific Host Biomarkers in QuantiFERON Supernatants as Candidates for the Diagnosis of Ocular Tuberculosis.

14. Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure.

15. Biomarkers of platelet activation and cardiovascular risk in the DAPT trial.

16. Development of a humanized mouse model to analyze antibodies specific for human leukocyte antigen (HLA).

17. Persistently higher serum sCD40L levels are associated with outcome in septic patients.

18. Biomarkers of Platelet Activation and Their Prognostic Value in Patients With Sepsis-Associated Disseminated Intravascular Coagulopathy.

19. Synergistic effect of collagen and CXCL12 in the low doses on human platelet activation.

20. Impact of immunosuppressive and antifungal drugs on PBMC- and whole blood-based flow cytometric CD154 + Aspergillus fumigatus specific T-cell quantification.

21. Serum sCD40L levels are increased in patients with psoriatic arthritis and are associated with clinical response to apremilast.

22. Soluble CD40 Ligand Levels in Children with Newly Diagnosed Graves’ Disease

23. CD154 (CD40L): A novel aid to document nonimmediate hypersensitivity to amoxicillin or amoxicillin clavulanic acid.

24. Elevation in Circulating Soluble CD40 Ligand Concentrations in Type 2 Diabetic Retinopathy and Association with its Severity.

25. Cytokine profiles in maternal serum are candidates for predicting an optimal timing for the delivery in early-onset fetal growth restriction.

26. An animal model of transfusion-related acute lung injury and the role of soluble CD40 ligand.

27. Soluble levels of sCD40L and s4-1BB are associated with a poor prognosis in elderly patients with colorectal cancer.

28. Platelet function and activation markers in primary hypercholesterolemia treated with anti-PCSK9 monoclonal antibody: A 12-month follow-up.

29. Vitamin D decreases CD40L gene expression in ulcerative colitis patients: A randomized, double-blinded, placebo-controlled trial.

30. CD154-expressing CMV-specific T cells associate with freedom from DNAemia and may be protective in seronegative recipients after liver or intestine transplantation.

31. Development and evaluation of a whole blood-based approach for flow cytometric quantification of CD154+ mould-reactive T cells.

32. The miR-145 rs353291 C allele increases susceptibility to atherosclerosis.

33. High Serum sCD40L Levels During the First Week of Malignant Middle Cerebral Artery Infarction and Mortality.

34. Association of soluble CD40L with short-term and long-term cardiovascular and all-cause mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.

35. Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients.

36. Association between CD40 polymorphisms and systemic lupus erythematosus and correlation between soluble CD40 and CD40 ligand levels in the disease: a meta-analysis.

37. Cytokines and related molecules, and adverse reactions related to platelet concentrate transfusions.

38. Association between the No-Reflow Phenomenon and Soluble CD40 Ligand Level in Patients with Acute ST-Segment Elevation Myocardial Infarction.

39. Nonsurviving Patients with Severe Traumatic Brain Injury Have Maintained High Serum sCD40L Levels.

40. Analysis of Genetic Variation in CD40 and CD40L: Relationship with mRNA Relative Expression and Soluble Proteins in Acute Coronary Syndrome.

41. Association of Platelet Binding to Lymphocytes with B Cell Abnormalities and Clinical Manifestations in Systemic Lupus Erythematosus.

42. Evaluation of serum sST2 and sCD40L values in patients with microvascular angina.

43. The changes in immune cell concentration during the progression of pre-diabetes to type 2 diabetes in a high-fat high-carbohydrate diet-induced pre-diabetic rat model.

44. Effects of three-month streptozotocin-induced diabetes in mice on blood platelet reactivity, COX-1 expression and adhesion potential.

45. Increased expression of the membrane-bound CD40 ligand on peripheral CD4 + T cells in the acute phase of AQP4-IgG-seropositive neuromyelitis optica spectrum disorders.

46. Serum Levels of Soluble CD40 Ligand and Neopterin in HIV Coinfected Asymptomatic and Symptomatic Visceral Leishmaniasis Patients.

47. Rosuvastatin stabilizes atherosclerotic plaques by reducing CD40L overexpression-induced downregulation of P4Hα1 in ApoE -/- mice.

48. Biomarkers of Thrombosis in ST-Segment Elevation Myocardial Infarction: A Substudy of the ATOLL Trial Comparing Enoxaparin Versus Unfractionated Heparin.

49. Investigation of association between CD40 current gene variants (rs4810485, rs1883832 and rs3765459) and serum CD154 protein levels in Iranian migraineurs.

50. Impact of Tobacco Versus Electronic Cigarette Smoking on Platelet Function.

Catalog

Books, media, physical & digital resources